Roseanne S. Wexler

735 total citations
11 papers, 599 citations indexed

About

Roseanne S. Wexler is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Roseanne S. Wexler has authored 11 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Biochemistry and 3 papers in Oncology. Recurrent topics in Roseanne S. Wexler's work include Eicosanoids and Hypertension Pharmacology (4 papers), Virus-based gene therapy research (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Roseanne S. Wexler is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (4 papers), Virus-based gene therapy research (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Roseanne S. Wexler collaborates with scholars based in United States, Australia and Italy. Roseanne S. Wexler's co-authors include Janet S. Kerr, Candy Robinson, Horace M. DeLisser, Cecília Garlanda, June Rae Merwin, Joseph A. Madri, Steven Μ. Albelda, Robert M. Strieter, Melpo Christofidou‐Solomidou and Marie D. Burdick and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Roseanne S. Wexler

11 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roseanne S. Wexler United States	7	273	109	84	75	63	11	599
Jean‐Dominique Guitton France	13	275 1.0×	80 0.7×	101 1.2×	106 1.4×	42 0.7×	16	555
Elisa Lorenzo Italy	6	475 1.7×	48 0.4×	142 1.7×	112 1.5×	144 2.3×	7	737
James M. Onoda United States	20	297 1.1×	165 1.5×	228 2.7×	137 1.8×	63 1.0×	33	794
Jelena Anacker Germany	9	343 1.3×	76 0.7×	189 2.3×	254 3.4×	105 1.7×	11	703
А. Ф. Карамышева Russia	7	342 1.3×	34 0.3×	155 1.8×	109 1.5×	45 0.7×	22	549
Françoise Fauvel-Lafève France	15	346 1.3×	101 0.9×	151 1.8×	155 2.1×	75 1.2×	23	709
Clive Long United Kingdom	11	193 0.7×	50 0.5×	45 0.5×	144 1.9×	76 1.2×	17	598
Maureen A. Nickols United States	9	284 1.0×	120 1.1×	201 2.4×	58 0.8×	49 0.8×	10	572
Trenis D. Palmer United States	12	332 1.2×	60 0.6×	195 2.3×	93 1.2×	64 1.0×	16	616
Tim Kute United States	9	326 1.2×	29 0.3×	110 1.3×	114 1.5×	89 1.4×	9	752

Countries citing papers authored by Roseanne S. Wexler

Since Specialization

Citations

This map shows the geographic impact of Roseanne S. Wexler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roseanne S. Wexler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roseanne S. Wexler more than expected).

Fields of papers citing papers by Roseanne S. Wexler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roseanne S. Wexler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roseanne S. Wexler. The network helps show where Roseanne S. Wexler may publish in the future.

Co-authorship network of co-authors of Roseanne S. Wexler

This figure shows the co-authorship network connecting the top 25 collaborators of Roseanne S. Wexler. A scholar is included among the top collaborators of Roseanne S. Wexler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roseanne S. Wexler. Roseanne S. Wexler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Mueller, Lauren, Roseanne S. Wexler, David A. Lovejoy, Robert B. Stein, & Andrew Slee. (2024). Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice. Psychopharmacology. 241(8). 1565–1575. 1 indexed citations

Murphy, Timothy M., et al.. (2021). Abstract P39: Pre-clinical evaluation of NEOS-223, an (S)-valine-thiazole derived peptidomimetic N-heterocycle, as an anticancer agent and P-glycoprotein inhibitor. Clinical Cancer Research. 27(6_Supplement). P39–P39. 1 indexed citations

Shumway, Stuart D., Amy D. Guertin, Melissa S. Hurd, et al.. (2011). Abstract 2969: A Wee1 kinase inhibitor, MK-1775, sensitizes cervical carcinoma cell lines to cisplatin and topotecan. Cancer Research. 71(8_Supplement). 2969–2969. 1 indexed citations

Cochran, Edward, James L. Ellis, David S. Garvey, et al.. (2007). Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors. Journal of Medicinal Chemistry. 50(25). 6367–6382. 45 indexed citations

Dhawan, Vijay, David J. Schwalb, Matthew J. Shumway, et al.. (2005). Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysis. Free Radical Biology and Medicine. 39(9). 1191–1207. 17 indexed citations

Wexler, Roseanne S., et al.. (2003). The Hollow Fiber Assay. Lung Cancer. 74. 545–566. 3 indexed citations

Wexler, Roseanne S., et al.. (2001). Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assay.. PubMed. 21(2A). 869–72. 8 indexed citations

Wexler, Roseanne S., et al.. (2000). The hollow fiber assay: continued characterization with novel approaches.. PubMed. 20(2A). 903–11. 40 indexed citations

Kerr, Janet S., Hui-Yin Li, Roseanne S. Wexler, et al.. (1997). THE CHARACTERIZATION OF POTENT NOVEL WARFARIN ANALOGS. Thrombosis Research. 88(2). 127–136. 9 indexed citations

10.

Zhang, Zhiyi, Janet S. Kerr, Roseanne S. Wexler, et al.. (1997). Warfarin Analog Inhibition of Human CYP2C9-Catalyzed S-Warfarin 7-Hydroxylation. Thrombosis Research. 88(4). 389–398. 14 indexed citations

11.

DeLisser, Horace M., Melpo Christofidou‐Solomidou, Robert M. Strieter, et al.. (1997). Involvement of endothelial PECAM-1/CD31 in angiogenesis.. PubMed. 151(3). 671–7. 460 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact